rs143236410

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_024408.4(NOTCH2):​c.6094C>A​(p.His2032Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00174 in 1,614,176 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0018 ( 3 hom. )

Consequence

NOTCH2
NM_024408.4 missense

Scores

1
6
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 8.19

Publications

16 publications found
Variant links:
Genes affected
NOTCH2 (HGNC:7882): (notch receptor 2) This gene encodes a member of the Notch family. Members of this Type 1 transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple, different domain types. Notch family members play a role in a variety of developmental processes by controlling cell fate decisions. The Notch signaling network is an evolutionarily conserved intercellular signaling pathway which regulates interactions between physically adjacent cells. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signaling pathway that plays a key role in development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remain to be determined. This protein is cleaved in the trans-Golgi network, and presented on the cell surface as a heterodimer. This protein functions as a receptor for membrane bound ligands, and may play a role in vascular, renal and hepatic development. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
NOTCH2 Gene-Disease associations (from GenCC):
  • acroosteolysis dominant type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • Alagille syndrome due to a NOTCH2 point mutation
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Alagille syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015488535).
BP6
Variant 1-119916628-G-T is Benign according to our data. Variant chr1-119916628-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 286650.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00127 (193/152286) while in subpopulation NFE AF = 0.00181 (123/68022). AF 95% confidence interval is 0.00155. There are 0 homozygotes in GnomAd4. There are 86 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 193 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOTCH2NM_024408.4 linkc.6094C>A p.His2032Asn missense_variant Exon 34 of 34 ENST00000256646.7 NP_077719.2 Q04721Q6IQ50Q9UFD5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOTCH2ENST00000256646.7 linkc.6094C>A p.His2032Asn missense_variant Exon 34 of 34 1 NM_024408.4 ENSP00000256646.2 Q04721

Frequencies

GnomAD3 genomes
AF:
0.00127
AC:
193
AN:
152168
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.0307
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000413
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00181
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00101
AC:
252
AN:
249248
AF XY:
0.00111
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.000636
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000647
Gnomad NFE exome
AF:
0.00149
Gnomad OTH exome
AF:
0.000978
GnomAD4 exome
AF:
0.00179
AC:
2622
AN:
1461890
Hom.:
3
Cov.:
32
AF XY:
0.00179
AC XY:
1302
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33480
American (AMR)
AF:
0.000760
AC:
34
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00116
AC:
100
AN:
86256
European-Finnish (FIN)
AF:
0.000449
AC:
24
AN:
53420
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.00211
AC:
2348
AN:
1112010
Other (OTH)
AF:
0.00171
AC:
103
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
167
335
502
670
837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00127
AC:
193
AN:
152286
Hom.:
0
Cov.:
33
AF XY:
0.00115
AC XY:
86
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.000385
AC:
16
AN:
41558
American (AMR)
AF:
0.00131
AC:
20
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4834
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00181
AC:
123
AN:
68022
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
12
24
36
48
60
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00159
Hom.:
0
Bravo
AF:
0.00145
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00198
AC:
17
ExAC
AF:
0.000980
AC:
119
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00142
EpiControl
AF:
0.00231

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 24, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30487145, 28776642, 24448499) -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NOTCH2: PP2, BS1 -

not specified Benign:1
Mar 17, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hajdu-Cheney syndrome Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

NOTCH2-related disorder Benign:1
Jun 11, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.21
CADD
Uncertain
24
DANN
Benign
0.97
DEOGEN2
Benign
0.30
T
Eigen
Uncertain
0.60
Eigen_PC
Pathogenic
0.69
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.96
D
M_CAP
Benign
0.021
T
MetaRNN
Benign
0.015
T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
1.5
L
PhyloP100
8.2
PrimateAI
Uncertain
0.77
T
PROVEAN
Uncertain
-4.2
D
REVEL
Uncertain
0.34
Sift
Benign
0.23
T
Sift4G
Benign
0.23
T
Polyphen
1.0
D
Vest4
0.59
MVP
0.71
MPC
0.52
ClinPred
0.042
T
GERP RS
5.8
Varity_R
0.25
gMVP
0.47
Mutation Taster
=63/37
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143236410; hg19: chr1-120459251; API